Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-09-11 | Dr. Steer is qualified to serve as a Director of the Company because his medical and scientific backgrounds, his experience in executive leadership and on boards, and his knowledge of the pharmaceutical and biotechnology industries all provide valuable strategic insight. |
| 2019-09-09 | Dr. Steer received his undergraduate degree in physiology and Ph.D. in pathobiology from the University of Minnesota and his medical degree from the Mayo Medical School. He offers the Board a strong medical and scientific background. |
| 2020-09-15 | Dr. Steer received his undergraduate degree in physiology and Ph.D. in pathobiology from the University of Minnesota and his medical degree from the Mayo Medical School. |
| 2021-09-14 | Dr. Steer offers the Board a strong medical and scientific background. Moreover, his experience in executive leadership and in board management, together with his knowledge of the pharmaceutical and biotechnology industries allow him to provide valuable strategic insight. Dr. Steer also offers an understanding of the development of the Company as the longest tenured member of the Board. |
| 2022-09-14 | Ph.D. in pathobiology, University of Minnesota, and medical degree from the Mayo Medical School. Dr. Steer offers the Board a strong medical and scientific background. |
| 2023-09-13 | Ph.D. in pathobiology, University of Minnesota, and medical degree from the Mayo Medical School. Dr. Steer is an independent biotechnology consultant and board director. |
Data sourced from SEC filings. Last updated: 2025-07-16